Novel Oral Anticoagulants in the Management of Polycythemia Vera and Essential Thrombocythemia

Author(s): Vasiliki Karali, Panayiotis Panayiotidis.

Journal Name: Cardiovascular & Hematological Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)

Volume 12 , Issue 1 , 2014

Become EABM
Become Reviewer


Polycythemia vera and essential thrombocythemia comprise myeloproliferative neoplasms, the main characteristic of which is an over-production of bone marrow myeloid lineage cells. The diseases typically involve thrombosis and their treatment, apart from the strictly hematological aspect, involves antithrombotic agents. In this review we aspire to present the possible role of the newly developed oral anticoagulants in the treatment scheme of polycythemia vera and essential thrombocythemia.

Keywords: Essential thrombocythemia, novel oral anticoagulants, polycythemia vera.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [26 - 28]
Pages: 3
DOI: 10.2174/187152571201141201092923

Article Metrics

PDF: 75